• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Top Pharmaceutical and Biotechnology Companies With Reknown Academia Scientists Reveal the Latest Inflammation and Auto-Immune Diseases Discoveries

Posted on: Monday, 27 November 2006, 09:01 CST

SAN FRANCISCO, Nov. 27 /PRNewswire/ -- Scientists and senior level management executives will gather to exchange the latest drug discovery and development techniques at the 11th Annual Inflammation & Immune Diseases Drug Discovery & Development Summit at the J.W. Marriott, San Francisco, CA, announces ALM's Strategic Research Institute.

The keynote addresses will be made by the following: Patient Heterogeneity in Osteoarthritis Rose A. Maciewicz, BA, MA, Ph.D, Chief Scientist, Respiratory & Inflammation Research Area AstraZeneca Drug Development in Autoimmunity: Changing the Paradigm Gary S. Firestein, M.D., Professor of Medicine Chief, Div of Rheumatology, Allergy and Immunology Director, UCSD Clinical Investigation Institute UCSD School of Medicine B Cells and Autoimmunity: A New Target for Intervention Peter E. Lipsky, M.D., Chief, Autoimmunity Branch NIAMS, NIH Development of Novel Approaches for Immunotherapy of RA Salvatore Albani, Professor of Medicine and Pediatrics UCSD

Complete list of participating companies and institutions includes: Altana, Amgen, Array Biopharma, AstraZeneca, Berlex, ChemoCentryx, Dynavax, MD Biosciences, Merck, Millennium, NIAMS, NIH, novosom AG, Rigel, Roche, Sirna Therapeutics, UCLA, UCSD, UCSF, University of Maryland, ZymoGenetics. The conference website is http://www.srinstitute.com/inflammation.

To receive the full agenda in PDF, register, or information on becoming a media partner or sponsorship/ exhibition opportunities, please contact Amy Yuehof Strategic Research Institute at ayueh@srinstitute.com or 212-967-0095, x258.

ABOUT STRATEGIC RESEARCH INSTITUTE

The Strategic Research Institute is part of ALM's Conference and Trade Show Division, one of North America's largest producers of educational and networking events for business leaders and the legal profession. The division offers more than 300 conferences and two leading industry tradeshows, as well as conferences in Europe and Asia. Attendance at the division's events, which span a broad range of topics including law, finance, natural resources, life sciences, multi-cultural marketing, real estate and healthcare, will exceed 40,000 executive-level decision makers this year.

ABOUT ALM

Headquartered in New York City, ALM is a leading integrated media company, focused on the legal and business communities. ALM currently owns and publishes 37 national and regional magazines and newspapers, including The American Lawyer(R), Corporate Counsel(R), The National Law Journal(R) and Real Estate Forum(R). Other ALM businesses include Law.com(R), the Web's leading legal news and information network, Law Journal Press books, newsletter publishing, court verdict and settlement reporting, production of professional educational seminars, market research and content distribution. ALM was formed by U.S. Equity Partners, L.P., a private equity fund sponsored by Wasserstein & Co., LP. More information on ALM's businesses and services is available on the Web at http://www.alm.com/.

Strategic Research Institute

CONTACT: Amy Yuehof of Strategic Research Institute, +1-212-967-0095,x258 ayueh@srinstitute.com

Web site: http://www.alm.com/http://www.srinstitute.com/inflammation

Source: PRNewswire

More News in this Category